Marksans Pharma Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 389.05 | 355.59 | 378.63 |
| Operating Expense | 255.58 | 264.28 | 248.37 |
| Net Profit | 91.92 | 60.91 | 99.81 |
| Net Profit Margin | 23.63% | 17.13% | 26.36% |
| Earning Per Share | 2.03 | 1.34 | 2.20 |
| EBIDTA | 131.14 | 90.94 | 129.40 |
| Effective Tax Rate | 22.56% | 22.83% | 15.98% |
Particulars
Mar 2026
Revenue389.05
Operating Expense255.58
Net Profit91.92
Net Profit Margin23.63
Earning Per Share2.03
EBIDTA131.14
Effective Tax Rate22.56
